Introduction: Psoriasis influences around 2% of the grown-up populace. Systemic treatments for direct to serious psoriasis have been connected to an expanded chance of upper respiratory viral tract disease. It is undetermined in the event that having psoriasis itself, having comorbidities related with psoriasis, or efficient medications for psoriasis clarify this relationship with COVID-19. Method: This precise survey incorporates looking the Google Scholar, PubMed and Web of Science databases utilizing the catchphrases psoriasis, coronavirus and COVID-19. The look was supplemented by manual looking of reference records of included articles. The look was upgraded in December 2019. Result:  the current writing may give a few clues for security contemplations. Ordinary immunosuppressive treatments like anti-tumor corruption and cyclosporine and methotrexate calculate specialists ought to not be favored due to expanded hazard of contamination, particularly in regions of high-risk. Due to the side impact of hypertension, which has been detailed to be related with defenselessness to serious COVID-19 utilize of cyclosporine might posture extra hazard. Conclusion: the present writing has given no final prove that increment in biologics the chance of COVID-19, extraction of these operators ought to be saved with COVID-19 side effects for patients. The approach of treatment ought to be modified, seeing the points of interest and drawbacks for each case independently.

Keywords: Psoriasis, COVID-19, Coronavirus